TRAIL is effective in many cancer cells, including colon, breast, lung, prostate, renal, ovarian, bladder, glioma, and pancreatic tumours (Walczak et al, 1999; Hylander et al, 2005; Shanker et al, 2008). This evidence concerns the gene TNFSF10 and cancer.